-
Je něco špatně v tomto záznamu ?
Alkylverdazyls as a Source of Alkyl Radicals for Light-Triggered Cancer Cell Death
DE. Votkina, EV. Plotnikov, PV. Petunin, ES. Berdinskaya, MS. Tretyakova, G. Audran, SRA. Marque, PS. Postnikov
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- buněčná smrt účinky léků MeSH
- fotochemoterapie metody MeSH
- fotosenzibilizující látky farmakologie MeSH
- lidé MeSH
- MFC-7 buňky účinky léků MeSH
- volné radikály metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Two alkylated verdazyl radicals (AlkVZs) were investigated as active compounds for photoinitiated controlled MCF-7 cell death. Observed results unambiguously showed that AlkVZ could be a potential structural moiety for the design of a novel family of photodynamic therapy agents. The main advantage of the proposed substances is an oxygen-independent generation of active radicals, which play a pivotal role in the treatment of oxygen-deficient tumors.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011406
- 003
- CZ-PrNML
- 005
- 20220506130425.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.molpharmaceut.1c00780 $2 doi
- 035 __
- $a (PubMed)34889598
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Votkina, Darya E $u Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russia
- 245 10
- $a Alkylverdazyls as a Source of Alkyl Radicals for Light-Triggered Cancer Cell Death / $c DE. Votkina, EV. Plotnikov, PV. Petunin, ES. Berdinskaya, MS. Tretyakova, G. Audran, SRA. Marque, PS. Postnikov
- 520 9_
- $a Two alkylated verdazyl radicals (AlkVZs) were investigated as active compounds for photoinitiated controlled MCF-7 cell death. Observed results unambiguously showed that AlkVZ could be a potential structural moiety for the design of a novel family of photodynamic therapy agents. The main advantage of the proposed substances is an oxygen-independent generation of active radicals, which play a pivotal role in the treatment of oxygen-deficient tumors.
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a volné radikály $x metabolismus $7 D005609
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a MFC-7 buňky $x účinky léků $7 D061986
- 650 _2
- $a fotochemoterapie $x metody $7 D010778
- 650 _2
- $a fotosenzibilizující látky $x farmakologie $7 D017319
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Plotnikov, Evgenii V $u Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russia
- 700 1_
- $a Petunin, Pavel V $u Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russia $1 https://orcid.org/0000000171015996
- 700 1_
- $a Berdinskaya, Elizaveta S $u Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russia
- 700 1_
- $a Tretyakova, Maria S $u Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russia
- 700 1_
- $a Audran, Gérard $u Aix Marseille University, CNRS, ICR, case 551, Avenue Escadrille Normandie-Niemen, 13397 Cedex 20 Marseille, France
- 700 1_
- $a Marque, Sylvain R A $u Aix Marseille University, CNRS, ICR, case 551, Avenue Escadrille Normandie-Niemen, 13397 Cedex 20 Marseille, France $1 https://orcid.org/0000000230508468
- 700 1_
- $a Postnikov, Pavel S $u Research School of Chemistry & Applied Biomedical Sciences, Tomsk Polytechnic University, 30 Lenin Avenue, Tomsk 634050, Russia $u Department of Solid-State Engineering, University of Chemistry and Technology, 16628 Prague, Czech Republic $1 https://orcid.org/0000000197131290
- 773 0_
- $w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 19, č. 1 (2022), s. 354-357
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34889598 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130417 $b ABA008
- 999 __
- $a ok $b bmc $g 1789142 $s 1162604
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 19 $c 1 $d 354-357 $e 20211210 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
- LZP __
- $a Pubmed-20220425